"L'IUCT Oncopole regroupe l'Institut Claudius Regaud et plusieurs services du CHU de Toulouse. Soin, recherche et enseignement en cancérologie."

During the past decade, Médecine Interne/IUCT Oncopole conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Médecine Interne/IUCT Oncopole" are "Myelodysplastic Syndromes" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Leukemia Acute Myeloid" (1 trials). Many other conditions were trialed in "Médecine Interne/IUCT Oncopole" in a lesser frequency.

Most popular intervention types in "Médecine Interne/IUCT Oncopole" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AG-120" (1 trials) and "AG-221" (1 trials). Other intervention names were less common.

The vast majority of trials in "Médecine Interne/IUCT Oncopole" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Médecine Interne/IUCT Oncopole". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Médecine Interne/IUCT Oncopole, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Médecine Interne/IUCT Oncopole, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".